Houston-based Polish scientists, Drs. Bogdan Czerniak and Marek Kimmel received over $10 million Grant from the National Institute of Health to study the biology of Bladder Cancer.

Drs. Bogdan Czerniak (left) and Marek Kimmel (right) discuss their collaborative
research related to the Bladder Cancer Program Project P01 grant funded by
the National Institutes of Health (NIH).

Bogdan Czerniak, M.D., Ph.D., Professor of Pathology at The University of Texas MD Anderson Cancer Center is a principal investigator of a recently awarded grant from the National Institute of Health to study the biology of early bladder cancer, which is expected to provide the foundation for more effective early detection, prevention, and therapies of this common human malignancy. Dr. Czerniak received his medical degree from Pomeranian Medical University in Szczecin, Poland and completed his doctoral and habilitation studies in the same institution. He did his residency in the United States at Montefiore Medical Center, New York followed by fellowship at Memorial Sloan Kettering Cancer Center in New York. Dr. Czerniak is an expert genitourinary, soft tissue, and skeletal pathologist who has been working at MD Anderson for more than three decades. In this grant, he closely collaborates with Dr. Marek Kimmel who is a Professor of Statistics and Bioengineering at Rice University in Houston. Dr. Kimmel received his Master of Science in Control Engineering and completed his doctoral studies in the Silesian University of Technology in Gliwice. He completed his habilitation in mathematics in the Jagiellonian University in Krakow and specializes in mathematical models of evolution of biological cells, with emphasis on cancer.